ESCO2 Antibody [PE]
Novus Biologicals, part of Bio-Techne | Catalog # NB100-87021PE
Conjugate
Catalog #
Key Product Details
Species Reactivity
Validated:
Human
Applications
Immunoprecipitation, Western Blot
Label
PE (Excitation = 488 nm, Emission = 575 nm)
Antibody Source
Polyclonal Rabbit IgG
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Summary for ESCO2 Antibody [PE]
Immunogen
The immunogen recognized by this antibody maps to a region between residue 200 and 250 of human establishment of cohesion 1 homolog 2 using the numbering given in entry NP_001017420.1 (GeneID 157570).
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Applications for ESCO2 Antibody [PE]
Application
Recommended Usage
Immunoprecipitation
Optimal dilutions of this antibody should be experimentally determined.
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Immunogen affinity purified
Formulation
PBS
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: ESCO2
Alternate Names
2410004I17Rik, EC 2.3.1.-, ECO1 homolog 2, EFO2, Establishment of cohesion 1 homolog 2, establishment of cohesion 1 homolog 2 (S. cerevisiae), N-acetyltransferase ESCO2, RBS, Roberts syndrome
Gene Symbol
ESCO2
Additional ESCO2 Products
Product Documents for ESCO2 Antibody [PE]
Product Specific Notices for ESCO2 Antibody [PE]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...